A 6-month-old boy was brought to the GP by his family who were concerned about his development. The GP tested his developmental milestones and found that he was able to hold objects with palmar grasp and pass objects from one hand to another. However, the child was not yet able to build a tower of 2 bricks, have a good pincer grip, or show a hand preference, which are expected milestones for older children. The GP reassured the family that the child’s development was within the normal range for his age.

Developmental Milestones for Fine Motor and Vision Skills

Fine motor and vision skills are important developmental milestones for infants and young children. These skills are crucial for their physical and cognitive development. The following tables provide a summary of the major milestones for fine motor and vision skills.

At three months, infants can reach for objects and hold a rattle briefly if given to their hand. They are visually alert, particularly to human faces, and can fix and follow objects up to 180 degrees. By six months, they can hold objects in a palmar grasp and pass them from one hand to another. They are visually insatiable, looking around in every direction.

At nine months, infants can point with their finger and demonstrate an early pincer grip. By 12 months, they have developed a good pincer grip and can bang toys together and stack bricks.

As children grow older, their fine motor skills continue to develop. By 15 months, they can build a tower of two blocks, and by 18 months, they can build a tower of three blocks. By two years old, they can build a tower of six blocks, and by three years old, they can build a tower of nine blocks. They also begin to draw, starting with circular scribbles at 18 months and progressing to copying vertical lines at two years old, circles at three years old, crosses at four years old, and squares and triangles at five years old.

In addition to fine motor skills, children’s vision skills also develop over time. At 15 months, they can look at a book and pat the pages. By 18 months, they can turn several pages at a time, and by two years old, they can turn one page at a time.

It is important to note that hand preference before 12 months is abnormal and may indicate cerebral palsy. Overall, these developmental milestones for fine motor and vision skills are important indicators of a child’s growth and development.

Understanding Nasolacrimal Duct Obstruction in Infants

Nasolacrimal duct obstruction is a common condition that affects around 10% of infants at one month of age. It is characterized by a persistent watery eye caused by an imperforate membrane, usually located at the lower end of the lacrimal duct. Fortunately, symptoms usually resolve on their own by the age of one year in 95% of cases.

To manage this condition, parents can be taught to massage the lacrimal duct to help clear any blockages. However, if symptoms persist beyond one year, it is recommended to seek the advice of an ophthalmologist. In such cases, probing may be considered, which is a procedure done under a light general anaesthetic. By understanding the causes and management of nasolacrimal duct obstruction, parents can take the necessary steps to ensure their child’s eye health and comfort.

Adults with polycystic kidney disease are at an increased risk of experiencing subarachnoid haemorrhage due to ruptured berry aneurysms. This is the most significant associated condition, as ADPKD is known to be linked with cerebral berry aneurysms that can rupture and cause subarachnoid haemorrhage. Liver cysts are the most common complication of ADPKD, while colonic diverticula and bowel obstruction are less frequent. Although ADPKD can cause splenic cysts and splenomegaly, this is also less common than the risk of subarachnoid haemorrhage due to cerebral berry aneurysms.

Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent genetic condition that affects approximately 1 in 1,000 Caucasians. The disease is caused by mutations in two genes, PKD1 and PKD2, which produce polycystin-1 and polycystin-2, respectively. ADPKD type 1 accounts for 85% of cases, while ADPKD type 2 accounts for the remaining 15%. Individuals with ADPKD develop multiple fluid-filled cysts in their kidneys, which can lead to renal failure.

To diagnose ADPKD in individuals with a positive family history, an abdominal ultrasound is typically performed. The diagnostic criteria for ultrasound include the presence of two cysts, either unilateral or bilateral, in individuals under 30 years of age, two cysts in both kidneys for those aged 30-59 years, and four cysts in both kidneys for those over 60 years of age.

Management of ADPKD may involve the use of tolvaptan, a vasopressin receptor 2 antagonist, for select patients. Tolvaptan has been recommended by NICE as an option for treating ADPKD in adults with chronic kidney disease stage 2 or 3 at the start of treatment, evidence of rapidly progressing disease, and if the company provides it with the agreed discount in the patient access scheme. The goal of treatment is to slow the progression of cyst development and renal insufficiency. An enlarged kidney with extensive cysts is a common finding in individuals with ADPKD.

Common Heart Conditions and Their Characteristics

Ventricular Septal Defect (VSD), Pulmonary Stenosis, Right Ventricular Outflow Tract (RVOT) Obstruction, Right Ventricular Hypertrophy, and Overriding of the VSD by the Aorta are all characteristics of Fallot’s Tetralogy, the most common form of cyanotic congenital heart disease. This condition presents with cyanotic episodes, typically at 1-2 months of age. Atrial Septal Defect (ASD) is not associated with Fallot’s Tetralogy. Pulmonary Regurgitation is not seen in Fallot’s Tetralogy, but rather Pulmonary Stenosis. A Continuous Murmur throughout Systole and Diastole is a characteristic of Patent Ductus Arteriosus (PDA). Hypoplastic Right Ventricle is not associated with Fallot’s Tetralogy, but rather Right Ventricular Hypertrophy.

For males with myoclonic seizures, sodium valproate is the recommended first-line treatment. This patient is experiencing clonus, which is the contracting and relaxing of both upper and lower limbs. Myoclonic epilepsy is the likely diagnosis as there are no signs of loss of consciousness, incontinence, tongue-biting, or postictal fatigue. Sodium valproate is the correct choice as it has been proven effective for this use through high-quality evidence. However, it is contraindicated for women of childbearing potential due to its teratogenic effects. Ethosuximide is not appropriate as it is used for absence seizures, which are characterized by staring blankly and being unresponsive, and typically occur in children aged 3-10 years. Lamotrigine is a third-line treatment option for myoclonic seizures in men, and levetiracetam is the second-line option for men and the first-line option for women of childbearing potential. In this case, it is best to try the first-line option of sodium valproate as the patient has not yet received any treatment and is male. If sodium valproate is unsuccessful, then levetiracetam may be considered.

Treatment for Epilepsy

Epilepsy is a neurological disorder that affects millions of people worldwide. The condition is characterized by recurrent seizures, which can be debilitating and life-threatening. Treatment for epilepsy typically involves the use of antiepileptic drugs (AEDs) to control seizures and improve quality of life.

According to NICE guidelines, AEDs should be started after the second epileptic seizure. However, if a patient has a neurological deficit, brain imaging shows a structural abnormality, the EEG shows unequivocal epileptic activity, or the patient or their family considers the risk of having a further seizure unacceptable, AEDs may be started after the first seizure. It is important to note that sodium valproate should not be used during pregnancy and in women of childbearing age unless clearly necessary due to the risk of neurodevelopmental delay in children.

The choice of AEDs depends on the type of epilepsy. For generalized tonic-clonic seizures, males are typically prescribed sodium valproate, while females are prescribed lamotrigine or levetiracetam. For focal seizures, lamotrigine or levetiracetam are the first-line treatments, with carbamazepine, oxcarbazepine, or zonisamide as second-line options. Ethosuximide is the first-line treatment for absence seizures, with sodium valproate or lamotrigine/levetiracetam as second-line options. For myoclonic seizures, males are prescribed sodium valproate, while females are prescribed levetiracetam. Finally, for tonic or atonic seizures, males are prescribed sodium valproate, while females are prescribed lamotrigine.

In summary, treatment for epilepsy involves the use of AEDs to control seizures and improve quality of life. The choice of AEDs depends on the type of epilepsy, and sodium valproate should be used with caution in women of childbearing age.

To treat gastric MALT lymphoma, it is recommended to eliminate H. pylori.

Gastric MALT Lymphoma: A Brief Overview

Gastric MALT lymphoma is a type of lymphoma that is commonly associated with H. pylori infection, which is present in 95% of cases. The good news is that this type of lymphoma has a good prognosis, especially if it is low grade. In fact, about 80% of patients with low-grade gastric MALT lymphoma respond well to H. pylori eradication.

One potential feature of gastric MALT lymphoma is the presence of paraproteinaemia, which is an abnormal protein in the blood. However, this is not always present and may not be a reliable indicator of the disease. Overall, gastric MALT lymphoma is a treatable form of lymphoma with a high likelihood of successful treatment.

The presence of systemic vasculitic symptoms, along with signs of hepatitis B and the absence of pulmonary symptoms, indicates that the patient may have polyarteritis nodosa. The patient’s symptoms appear to be viral, except for the presence of itchiness, scleral jaundice, haematuria, and purpura, which suggest vasculitis. The absence of respiratory symptoms helps to eliminate other possible diagnoses, such as polymyalgia rheumatica. The patient’s scleral jaundice and itchiness may indicate obstructive hepatic impairment. Polyarteritis nodosa is strongly associated with hepatitis B infection and does not typically present with respiratory symptoms, unlike other types of vasculitis.

Polyarteritis Nodosa: Symptoms, Features, and Diagnosis

Polyarteritis nodosa (PAN) is a type of vasculitis that affects medium-sized arteries, causing inflammation and aneurysm formation. It is more common in middle-aged men and is often associated with hepatitis B infection. Symptoms of PAN include fever, malaise, weight loss, hypertension, and joint pain. It can also cause nerve damage, testicular pain, and a skin condition called livedo reticularis. In some cases, patients may experience kidney damage and renal failure. Diagnosis of PAN may involve testing for perinuclear-antineutrophil cytoplasmic antibodies (ANCA) and hepatitis B serology. Angiograms may also be used to detect changes in the affected arteries.

Treatment Options for Bleeding in Patients on Warfarin

Patients on warfarin, an oral anticoagulant commonly used to reduce the risk of stroke in patients with atrial fibrillation, may experience bleeding complications. In such cases, it is important to consider appropriate treatment options. One such option is the administration of vitamin K, which is required as a co-enzyme for coagulation factors II, VII, IX, and X. Warfarin’s mechanism of action is as a vitamin K antagonist, and thus, its effects can be reversed by vitamin K. Fresh frozen plasma (FFP) may be used in patients with significant coagulopathy, but it is unlikely to be indicated in patients on warfarin. Prothrombin complex concentrate, such as Beriplex or Octoplex, can also be used to reverse the action of warfarin, but it may be associated with allergic reactions. Factor VIII is used in the treatment of von Willebrand’s disease, a common inherited bleeding disorder. Blood transfusion with packed red blood cells may be appropriate if the patient has had a significant reduction in haemoglobin levels, but continued blood transfusion is unhelpful unless the bleeding is stopped. In summary, the appropriate treatment option for bleeding in patients on warfarin depends on the severity of bleeding and the patient’s medical history.

Differential diagnosis of a patient with low vitamin B12 and related symptoms

Pernicious anaemia, coeliac disease, Crohn’s disease, and multiple myeloma are among the possible conditions that may cause low vitamin B12 levels and related symptoms. Pernicious anaemia is an autoimmune disorder that affects the gastric mucosa and impairs the production of intrinsic factor, leading to vitamin B12 deficiency and anaemia. Coeliac disease is a chronic immune-mediated enteropathy that affects the small intestine and causes malabsorption of nutrients, including vitamin B12. Crohn’s disease is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract and cause various symptoms, including diarrhoea, abdominal pain, and weight loss. Multiple myeloma is a malignant plasma cell disorder that can cause bone pain, anaemia, and other symptoms, but is less likely to present with low vitamin B12 levels as the primary feature.

The differential diagnosis of these conditions may involve various tests and procedures, such as blood tests for antibodies and vitamin B12 levels, endoscopy with biopsies of the duodenum or colon, and bone marrow examination. The specific findings on these tests can help to distinguish between the different conditions and guide further management. For example, the presence of parietal cell antibodies and intrinsic factor antibodies in the blood may support a diagnosis of pernicious anaemia, while villous atrophy and crypt hyperplasia in the duodenal biopsies may suggest coeliac disease. Transmural inflammation with granuloma formation in the colon biopsies may indicate Crohn’s disease, while plasma cell infiltration in the bone marrow may suggest multiple myeloma.

Overall, the diagnosis of a patient with low vitamin B12 and related symptoms requires a thorough evaluation of the clinical history, physical examination, and laboratory findings, as well as consideration of the possible differential diagnoses.

Differentiating Chronic Kidney Disease from Acute Renal Failure

Chronic kidney disease (CKD) and acute renal failure (ARF) can both result in elevated creatinine levels, but other factors can help differentiate between the two conditions. In the case of a patient with hypocalcaemia, hyperphosphataemia, and an elevation of parathyroid hormone, CKD is more likely than ARF. These metabolic changes are commonly seen in CKD 4-5 and are not typically present in ARF of short duration. Additionally, the relatively higher creatinine result compared to urea suggests CKD rather than ARF, which can be caused by dehydration and result in even higher urea levels.

This patient likely has CKD and may already be dependent on dialysis or under regular review by a nephrology team. The decision to start dialysis is based on various factors, including fluid overload, hyperkalaemia, uraemic symptoms, life expectancy, and patient/clinician preference. Most patients begin dialysis with an eGFR of around 10 ml/min/1.73m2.

Bone Disorders: Osteomalacia, Osteoporosis, Paget’s Disease, Myeloma, and Bone Metastases

Osteomalacia is a condition where there is insufficient mineralization of bone, resulting in softening of the bone. This is caused by a decrease in plasma PO43− and Ca2+ levels, and an increase in alkaline phosphatase due to increased bone turnover. It can be caused by various factors such as vitamin D deficiency, renal failure, medications, tumors, or liver disease.

Osteoporosis, on the other hand, is associated with normal plasma PO43−, Ca2+, and alkaline phosphatase levels. Paget’s disease is caused by increased bone turnover, resulting in elevated alkaline phosphatase levels, but normal plasma PO43− and Ca2+ levels.

Myeloma and bone metastases both cause raised plasma Ca2+ levels, but the distinguishing feature is the alkaline phosphatase level. Myeloma has normal alkaline phosphatase levels, while bone metastases have elevated levels.

It is important to note that in interpreting calcium levels, only the total calcium concentration is given, not corrected calcium. Alterations in serum protein concentration directly affect the total blood calcium concentration, even if the ionized calcium concentration remains normal. An algorithm to correct for protein changes is to adjust the total serum calcium upward by 0.8 times the deficit in serum albumin or by 0.5 times the deficit in serum immunoglobulins. However, in this question, the serum albumin value is within normal limits, hence no correction for total calcium is required.

Overall, understanding the differences between these bone disorders and their associated laboratory findings is crucial in making an accurate diagnosis and providing appropriate treatment.

Prescribing pyridoxine can help lower the risk of peripheral neuropathy associated with isoniazid.

Side-Effects and Mechanism of Action of Tuberculosis Drugs

Rifampicin is a drug that inhibits bacterial DNA dependent RNA polymerase, which prevents the transcription of DNA into mRNA. However, it is a potent liver enzyme inducer and can cause hepatitis, orange secretions, and flu-like symptoms.

Isoniazid, on the other hand, inhibits mycolic acid synthesis. It can cause peripheral neuropathy, which can be prevented with pyridoxine (Vitamin B6). It can also cause hepatitis and agranulocytosis. Additionally, it is a liver enzyme inhibitor.

Pyrazinamide is converted by pyrazinamidase into pyrazinoic acid, which in turn inhibits fatty acid synthase (FAS) I. However, it can cause hyperuricaemia, leading to gout, as well as arthralgia, myalgia, and hepatitis.

Lastly, Ethambutol inhibits the enzyme arabinosyl transferase, which polymerizes arabinose into arabinan. It can cause optic neuritis, so it is important to check visual acuity before and during treatment. Additionally, the dose needs adjusting in patients with renal impairment.

In summary, these tuberculosis drugs have different mechanisms of action and can cause various side-effects. It is important to monitor patients closely and adjust treatment accordingly to ensure the best possible outcomes.

Temporal arthritis and its Consequences

Temporal arthritis, also known as giant cell arthritis, is a condition that commonly affects the temporal artery. Its classic symptoms include headache, scalp tenderness, and jaw claudication. If left untreated, it can lead to involvement of other branches of the external carotid artery, with the ophthalmic branch being the worst affected. This can cause blindness due to ischaemic optic neuropathy, central retinal artery occlusion, or cortical infarction. Although corticosteroid therapy can reduce symptoms, established blindness is irreversible. Therefore, it is crucial to diagnose and treat temporal arthritis promptly to prevent severe consequences.

Antimuscarinic medications are effective in managing symptoms of overactive bladder. This condition is characterized by storage symptoms such as urinary urgency, frequency, and nocturia, often caused by detrusor overactivity. Oxybutynin is an example of an antimuscarinic drug that can increase bladder capacity by relaxing the detrusor’s smooth muscle, thereby reducing overactive bladder symptoms. Other antimuscarinic drugs include tolterodine and darifenacin. While botulinum toxin injection is an invasive treatment option for overactive bladder, it is not typically the first choice. Finasteride, a 5 alpha-reductase inhibitor, is not indicated for overactive bladder treatment as it is used to decrease prostate size in BPH patients. Mirabegron, a beta-3 adrenergic receptor agonist, can also relax the detrusor’s smooth muscle, but it is only recommended when antimuscarinic drugs are not effective or contraindicated due to side effects.

Lower urinary tract symptoms (LUTS) are a common issue in men over the age of 50, with benign prostatic hyperplasia being the most common cause. However, other causes such as prostate cancer should also be considered. These symptoms can be classified into three groups: voiding, storage, and post-micturition. To properly manage LUTS, it is important to conduct a urinalysis to check for infection and haematuria, perform a digital rectal examination to assess the size and consistency of the prostate, and possibly conduct a PSA test after proper counselling. Patients should also complete a urinary frequency-volume chart and an International Prostate Symptom Score to guide management.

For predominantly voiding symptoms, conservative measures such as pelvic floor muscle training, bladder training, and prudent fluid intake can be helpful. If symptoms are moderate or severe, an alpha-blocker may be offered. If the prostate is enlarged and the patient is at high risk of progression, a 5-alpha reductase inhibitor should be offered. If there are mixed symptoms of voiding and storage not responding to an alpha-blocker, an antimuscarinic drug may be added. For predominantly overactive bladder symptoms, moderating fluid intake and bladder retraining should be offered, and antimuscarinic drugs may be prescribed if symptoms persist. Mirabegron may be considered if first-line drugs fail. For nocturia, moderating fluid intake at night, furosemide 40 mg in the late afternoon, and desmopressin may be helpful.

Understanding Tetralogy of Fallot

Tetralogy of Fallot (TOF) is a congenital heart disease that results from the anterior malalignment of the aorticopulmonary septum. It is the most common cause of cyanotic congenital heart disease, and it typically presents at around 1-2 months, although it may not be detected until the baby is 6 months old. The condition is characterized by four features, including ventricular septal defect (VSD), right ventricular hypertrophy, right ventricular outflow tract obstruction, and overriding aorta. The severity of the right ventricular outflow tract obstruction determines the degree of cyanosis and clinical severity.

Other features of TOF include cyanosis, which may cause episodic hypercyanotic ‘tet’ spells due to near occlusion of the right ventricular outflow tract. These spells are characterized by tachypnea and severe cyanosis that may occasionally result in loss of consciousness. They typically occur when an infant is upset, in pain, or has a fever, and they cause a right-to-left shunt. Additionally, TOF may cause an ejection systolic murmur due to pulmonary stenosis, and a right-sided aortic arch is seen in 25% of patients. Chest x-ray shows a ‘boot-shaped’ heart, while ECG shows right ventricular hypertrophy.

The management of TOF often involves surgical repair, which is usually undertaken in two parts. Cyanotic episodes may be helped by beta-blockers to reduce infundibular spasm. However, it is important to note that at birth, transposition of the great arteries is the more common lesion as patients with TOF generally present at around 1-2 months. Understanding the features and management of TOF is crucial for healthcare professionals to provide appropriate care and treatment for affected infants.

Vitamin supplementation containing vitamins C and E, beta-carotene, and zinc can delay the progression of dry age-related macular degeneration (AMD) from intermediate to advanced stages. However, there is no other treatment available for dry AMD, and management is mainly supportive. Pan-retinal photocoagulation is not used for either dry or wet AMD. Anti-vascular endothelial growth factor (VEGF) intravitreal injection is reserved for wet AMD, where there is choroidal neovascularization. This treatment stops abnormal blood vessels from leaking, growing, and bleeding under the retina. Focal laser photocoagulation is sometimes used in wet AMD, but anti-VEGF injections are now the preferred treatment. Photodynamic therapy can be used in wet AMD when anti-VEGF is not an option or for those who do not want repeated intravitreal injections. The patient in question has dry AMD, with metamorphopsia as a symptom and yellow deposits at the macula known as drusen.

Common Congenital Abnormalities of the Gastrointestinal Tract in Infants

Infants can experience various congenital abnormalities of the gastrointestinal tract, which can lead to serious health complications. Here are some of the most common abnormalities and their characteristics:

Infantile Pyloric Stenosis
This condition occurs due to hypertrophy and hyperplasia of the pyloric muscle, leading to obstruction of the gastric outlet. Symptoms include non-bilious projectile vomiting within half an hour from feeding and failure to thrive. Diagnosis is via ultrasound, and treatment involves Ramstedt pyloromyotomy.

Meckel’s Diverticulum
This is the most common congenital abnormality of the small intestine, caused by persistence of the vitelline duct. Patients are usually asymptomatic, but can present with painless rectal bleeding, signs of obstruction, or acute appendicitis-like symptoms. Treatment involves excision of the diverticulum and adjacent ileal segment.

Malrotation of the Small Intestine with Volvulus
This occurs due to disrupted development of the bowel during the embryonic period. It can present acutely as a volvulus with abdominal pain and bilious vomiting. Treatment involves surgical intervention.

Hirschsprung’s Disease
This is a congenital disorder caused by absent ganglia in the distal colon, resulting in functional obstruction. Infants present within the first 48 hours of life, having not passed meconium. Diagnosis is via rectal biopsy, and treatment involves surgical intervention.

Imperforate Anus
This is a congenital malformation occurring with an incidence of 1 in 5000 births. Infants may have abdominal distension and fail to produce meconium. Treatment involves intravenous hydration and surgical evaluation.

In conclusion, early diagnosis and prompt treatment of these congenital abnormalities are crucial for the health and well-being of infants.

When dealing with patients who have urinary incontinence, it is crucial to eliminate the possibility of a UTI and diabetes mellitus as underlying causes. The first step in investigating urinary incontinence would be to conduct a urine dipstick and culture test, which can be easily done in a GP’s office. Other initial investigations include keeping a bladder diary for at least three days and undergoing urodynamic studies. It is important to note that the reliability of urine dip tests is questionable in women over 65 years of age and those who have catheters. A three-day bladder diary is necessary for initial investigations, and a one-day diary would not suffice. CT scans are not typically used to investigate urinary incontinence but are useful in detecting renal pathology such as ureteric calculi. Cystoscopy is not appropriate for this patient and is usually reserved for cases where bladder cancer is suspected.

Understanding Urinary Incontinence: Causes, Classification, and Management

Urinary incontinence (UI) is a common condition that affects around 4-5% of the population, with elderly females being more susceptible. Several risk factors contribute to UI, including advancing age, previous pregnancy and childbirth, high body mass index, hysterectomy, and family history. UI can be classified into different types, such as overactive bladder (OAB)/urge incontinence, stress incontinence, mixed incontinence, overflow incontinence, and functional incontinence.

Initial investigation of UI involves completing bladder diaries for at least three days, vaginal examination, urine dipstick and culture, and urodynamic studies. Management of UI depends on the predominant type of incontinence. For urge incontinence, bladder retraining and bladder stabilizing drugs such as antimuscarinics are recommended. For stress incontinence, pelvic floor muscle training and surgical procedures such as retropubic mid-urethral tape procedures may be offered. Duloxetine, a combined noradrenaline and serotonin reuptake inhibitor, may also be used as an alternative to surgery.

In summary, understanding the causes, classification, and management of UI is crucial in providing appropriate care for patients. Early diagnosis and intervention can significantly improve the quality of life for those affected by this condition.

Facts about Digoxin: Myths and Truths

Digoxin is a medication commonly used to treat heart conditions such as atrial fibrillation and heart failure. However, there are several misconceptions about this drug that need to be clarified. Here are some facts about digoxin:

Visual Disturbance is a Feature of Digoxin Toxicity: One of the side effects of digoxin toxicity is a yellow visual disturbance. This can be caused by hypokalaemia and hypercalcaemia.

Digoxin is Not the Treatment of Choice for Ventricular Fibrillation: Contrary to popular belief, digoxin is not the treatment of choice for ventricular fibrillation. Defibrillation is the preferred treatment.

Digoxin Does Not Cardiovert Atrial Fibrillation: While digoxin can control the rate of atrial fibrillation by slowing AV conduction, it does not commonly cardiovert AF. Intravenous digoxin may be used to cardiovert some cases of AF, but it is not the first-line treatment.

Hyperkalaemia Potentiates Digoxin Toxicity: High levels of potassium in the blood can increase the risk of digoxin toxicity.

Digoxin is Excreted Unchanged by the Kidneys: Digoxin is not metabolised by the liver. Instead, it is excreted unchanged by the kidneys.

In conclusion, it is important to understand the facts about digoxin to ensure safe and effective use of this medication.

The combined oral contraceptive has only one absolute contraindication in a patient’s history, which is factor V Leiden (a UKMEC 4 level indicating an unacceptable health risk). Other elements of the patient’s history fall into UKMEC 3, where the disadvantages generally outweigh the benefits. However, it is important to note that some concurrent UKMEC 3 contraindications may become absolute contraindications when combined. Therefore, it is crucial to carefully study guidelines before prescribing.

The decision to prescribe the combined oral contraceptive pill is now based on the UK Medical Eligibility Criteria (UKMEC), which categorizes potential contraindications and cautions on a four-point scale. UKMEC 1 indicates no restrictions for use, while UKMEC 2 suggests that the benefits outweigh the risks. UKMEC 3 indicates that the disadvantages may outweigh the advantages, and UKMEC 4 represents an unacceptable health risk. Examples of UKMEC 3 conditions include controlled hypertension, a family history of thromboembolic disease in first-degree relatives under 45 years old, and current gallbladder disease. Examples of UKMEC 4 conditions include a history of thromboembolic disease or thrombogenic mutation, breast cancer, and uncontrolled hypertension. Diabetes mellitus diagnosed over 20 years ago is classified as UKMEC 3 or 4 depending on severity. In 2016, Breastfeeding between 6 weeks and 6 months postpartum was changed from UKMEC 3 to UKMEC 2.